VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
ONC
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
ONCBeOne Medicines Ltd.
$279.89$29.9B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksONCPrice Target
ONC logo

BeOne Medicines Ltd. (ONC) Price Target Analysis

Updated Jun 26, 2026
Analyst Rating: Buy
Based on 14 analysts

42.6% Below Target

ONC trades 42.6% below Wall Street's consensus target of $399.11.

Current Price$279.89
Average Target$399.11
Target
Current
Low$340.00
Median$409.00
High$436.00

Analyst Target Range

Forward P/E41.6x
(Growth Premium)
PEG Ratio—
Implied Growth+51.9%
(High Growth)
Analyst Spread24.1%
(High Agreement)

Price Forecast (1 Year)

Last 12 months price action with 12-month analyst target path

Current$279.89
Consensus$399.11
High$436.00
Low$340.00

Consensus Scenario Assumptions

The base valuation assumes ONC achieves its forward estimates and maintains a stable P/E multiple of 41.6x. This scenario reflects the blended consensus of 14 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.

Analyst Ratings Distribution

Breakdown of 14 published analyst recommendations for ONC

13/14 analysts are bullish
+46
BearishBullish
Weighted analyst sentiment score based on 14 ratings
ConsensusBuy
Coverage14 Analysts
Net Score+46
Bull / Bear93% / 0%
Strong Buy00%
Buy1393%
Hold17%
Sell00%
Strong Sell00%
Strong Buy
00%
Buy
1393%
Hold
17%
Sell
00%
Strong Sell
00%
Recommendation Mix93% Buy · 7% Hold · 0% Sell
Buy (13)Hold (1)Sell (0)

ONC Price Target Analysis

Updated June 29, 2026

As of June 29, 2026, BeOne Medicines Ltd. (ONC) has a Wall Street consensus price target of $399.11, based on estimates from 14 covering analysts. With the stock currently trading at $279.89, this represents a potential upside of +42.6%. The company has a market capitalization of $29.91B.

Analyst price targets range from a low of $340.00 to a high of $436.00, representing a 24% spread in expectations. The median target of $409.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.

The current analyst consensus rating is Buy, with 13 analysts rating the stock as a Buy or Strong Buy,1 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.

From a valuation perspective, ONC trades at a trailing P/E of 8.5x and forward P/E of 41.6x. Analysts expect EPS to grow +51.9% over the next year.

Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $26.97, with bear and bull scenarios of $16.99 and $35.53 respectively. Model confidence stands at 57/100, reflecting moderate uncertainty in projections.

Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Healthcare stocks.

Analyst Sentiment Comparison

Industry Peer Analysis
Avg Peer Upside
+20.2%
Industry Consensus
Avg Forward P/E
44.8x
(Growth Premium)
Peers with Coverage
10 / 10
Active Analyst Tracking
CompanyMarket CapPriceTargetUpside PotentialRatingFwd P/EAnalysts
ZYME logo
ZYMEZymeworks Inc.
$1.8B$24.15$40.67
+68.4%
Buy17.7x20
RCUS logo
RCUSArcus Biosciences, Inc.
$3.1B$31.00$31.00
+0.0%
Buy—18
TGTX logo
TGTXTG Therapeutics, Inc.
$8.5B$55.83$64.00
+14.6%
Buy41.1x13
KYMR logo
KYMRKymera Therapeutics, Inc.
$8.8B$108.12$123.50
+14.2%
Buy—26
MGNX logo
MGNXMacroGenics, Inc.
$306M$4.81$6.00
+24.7%
Buy—22
IMVT logo
IMVTImmunovant, Inc.
$8.0B$38.85$45.00
+15.8%
Buy—23
HALO logo
HALOHalozyme Therapeutics, Inc.
$8.9B$74.96$88.25
+17.7%
Buy9.2x27
ACAD logo
ACADACADIA Pharmaceuticals Inc.
$4.3B$25.32$33.67
+33.0%
Buy65.1x37
FOLD logo
FOLDAmicus Therapeutics, Inc.
$4.5B$14.49$14.50
+0.1%
Buy40.6x24
PTCT logo
PTCTPTC Therapeutics, Inc.
$7.0B$84.43$95.83
+13.5%
Buy95.3x26

ONC — Frequently Asked Questions

Quick answers to the most common questions about buying ONC stock.

What is the ONC stock price target for 2026?

The consensus Wall Street price target for ONC is $399.11, representing 42.6% upside from the current price of $279.89. With 14 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.

Is ONC a buy, sell, or hold?

ONC has a consensus rating of "Buy" based on 14 Wall Street analysts. The rating breakdown is predominantly bullish, with 13 Buy/Strong Buy ratings. The consensus 12-month price target of $399.11 implies 42.6% upside from current levels.

Is ONC stock overvalued or undervalued?

At a forward P/E of 41.5816x, ONC trades at a premium valuation. The consensus price target of $399.11 (42.6% upside) suggests analysts still see growth justifying the multiple.

How high can ONC stock go?

The most bullish Wall Street analyst has a price target of $436 for ONC, while the most conservative target is $340. The consensus of $399.11 represents the median expectation. Our quantitative valuation model projects a bull case target of $36 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.

How many analysts cover ONC stock?

ONC is moderately covered, with 14 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 13 have Buy ratings, 1 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.

What is the ONC stock forecast?

The 12-month ONC stock forecast based on 14 Wall Street analysts shows a consensus price target of $399.11, with estimates ranging from $340 (bear case) to $436 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $27, with bear/bull scenarios of $17/$36.

What is ONC's fair value based on fundamentals?

Our quantitative valuation model calculates ONC's fair value at $27 (base case), with a bear case of $17 and bull case of $36. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 57/100.

What is ONC's forward P/E ratio?

ONC trades at a forward P/E ratio of 41.6x based on next-twelve-months earnings estimates compared to a trailing P/E of 8.5x. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.

Should I buy ONC stock?

Wall Street analysts are very optimistic on ONC, with a "Buy" consensus rating and $399.11 price target (42.6% upside). 13 of 14 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.

Why do ONC price targets vary so much?

ONC analyst price targets range from $340 to $436, a 24% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $399.11 consensus represents the middle ground. Our model's $17-$36 range provides an independent fundamental perspective.

Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare